{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:41:51Z","timestamp":1778575311647,"version":"3.51.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Transjugular intrahepatic portosystemic shunt (TIPS) has been performed on patients with cirrhosis and portal vein thrombosis (PVT) to prevent rebleeding; however, the associated evidence is scarce. Hence, the study aimed to evaluate the feasibility and efficacy of TIPS in patients with cirrhosis and PVT and promote personalized treatment in such patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Literature was systematically obtained from PubMed, EMBASE, Cochrane Library, and Web of Science. Data from the included studies were extracted, and meta-analyses by the random effects model were used to pool data across studies. Heterogeneity was assessed using Cochran\u2019s Q and I<jats:sup>2<\/jats:sup> statistics. The source of heterogeneity was explored using subgroup analyses and meta-regressions.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 11 studies comprising 703 patients with cirrhosis and portal vein thrombosis (PVT: complete, 32.2%; chronic, 90.2%; superior mesenteric vein or splenic vein involvement, 55.2%; cavernous transformation, 26.8%) were included. TIPS showed feasibility in 95% of the cases (95% confidence interval [CI]: 89%\u201399%) with heterogeneity (I<jats:sup>2<\/jats:sup> = 84%, <jats:italic>p<\/jats:italic> &amp;lt; 0.01) due to cavernous transformation. The pooled rebleeding rate was 13% (95% CI: 7%\u201320%) with heterogeneity (I<jats:sup>2<\/jats:sup> = 75%, <jats:italic>p<\/jats:italic> &amp;lt; 0.01) explained by chronic PVT and anticoagulation (AC) therapy. Hepatic encephalopathy occurred in 32% of patients. The survival rate, portal vein recanalization rate, and shunt patency rate were 80%, 82%, and 77%, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> TIPS is feasible and effectively prevents rebleeding in patients with cirrhosis and PVT, regardless of cavernous transformation of the portal vein. Due to a potentially high risk of rebleeding and no apparent benefits of AC, post-TIPS AC must be employed cautiously.<\/jats:p><jats:p><jats:bold>Systematic Review Registration<\/jats:bold>: [<jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=258765<\/jats:ext-link>], identifier [CRD42021258765].<\/jats:p>","DOI":"10.3389\/fphar.2022.968988","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T06:42:51Z","timestamp":1660632171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ding-Fan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J. Epidemiol. Community Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.23383","article-title":"The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: Update 2009","volume":"51","author":"Boyer","year":"2010","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","article-title":"Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: Long-term results of a randomized multicentre study","volume":"27","author":"Bureau","year":"2007","journal-title":"Liver Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation","volume":"46","author":"Dell'Era","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"","journal-title":"Liver Transpl."},{"key":"B7","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"","journal-title":"Liver Transpl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.3748\/wjg.v21.i22.6769","article-title":"Portal vein thrombosis in cirrhosis: Controversies and latest developments","volume":"21","author":"Harding","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"B14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3760\/cma.j.cn501113-20200616-00326","article-title":"Zhonghua Gan Zang Bing Za Zhi","author":"Huang","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol. Methods"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.diii.2016.07.005","article-title":"Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis","volume":"97","author":"Lakhoo","year":"2016","journal-title":"Diagn. Interv. Imaging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1007\/s00330-018-5360-z","article-title":"Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy","volume":"28","author":"Luo","year":"2018","journal-title":"Eur. Radiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced cirrhosis combined with portal vein thrombosis: A randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: A prospective observational study","volume":"116","author":"Lv","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: A randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.cld.2014.07.006","article-title":"Transjugular intrahepatic portosystemic shunt","volume":"18","author":"Patidar","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","article-title":"Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial","volume":"60","author":"Perarnau","year":"2014","journal-title":"J. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrgastro.2014.36","article-title":"Management of portal vein thrombosis in liver cirrhosis","volume":"11","author":"Qi","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/liv.12929","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: Outcomes and predictors in a prospective cohort study","volume":"36","author":"Qi","year":"2016","journal-title":"Liver Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: Portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12072-010-9236-9","article-title":"Diagnosis and management of acute variceal bleeding: Asian pacific association for study of the liver recommendations","volume":"5","author":"Sarin","year":"2011","journal-title":"Hepatol. Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"B28","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e8678","DOI":"10.1097\/MD.0000000000008678","article-title":"Use of concomitant variceal embolization and prophylactic antiplatelet\/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients","volume":"96","author":"Tang","year":"2017","journal-title":"Med. Baltim."},{"key":"B30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00270-005-0090-4","article-title":"Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis","volume":"29","author":"Van Ha","year":"2006","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00261-014-0320-9","article-title":"Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis","volume":"40","author":"Wang","year":"2015","journal-title":"Abdom. Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: Outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.12998\/wjcc.v9.i19.5179","article-title":"Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.968988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T06:43:06Z","timestamp":1660632186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.968988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":35,"alternative-id":["10.3389\/fphar.2022.968988"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.968988","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"968988"}}